EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents

Esraa Yasser Rabea iD, Esraa Dakrory Mahmoud, Nada Khaled Mohamed, Erada Rabea Ansary, Mahmoud Roushdy Alrouby, Rabab Reda Shehata, Youssef Yasser Mokhtar, Prakash Arullampalam, Ahmed M Hegazy iD, Ahmed Al-Sabi iD, Tarek Mohamed Abd El-Aziz iD

Toxins · 11.05.2025 · 17 (5) · 238

DOI: 10.3390/toxins17050238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 11.05.2025. Verfasst von Esraa Yasser Rabea und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Division, Chemistry Department, Faculty of Science, Minia University, El-Minia 61519, Egypt. Hauptthemen laut MEDLINE: Anti-Infective Agents, Venoms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Integrative Studies at Abdullah Al Salem University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of antimicrobial resistance is a significant challenge in global healthcare, necessitating innovative techniques to address multidrug-resistant pathogens. Multidrug-resistant pathogens like Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa pose significant public health threats, as they are increasingly resistant to common antibiotics, leading to more severe and difficult-to-treat infections. These pathogens are part of the ESKAPE group, which includes Enterococcus faecium, Staphylococcus aureus, and Enterobacter species. Animal venoms, derived from a wide range of species such as snakes, scorpions, spiders, bees, wasps, and ants, represent a rich source of bioactive peptides. Venoms have been a valuable source for drug discovery, providing unique compounds with therapeutic potential. Venom-derived drugs are known for their increased bioactivity, specificity, and stability compared to synthetic alternatives. These compounds are being investigated for various conditions, including treatments for diabetes, pain relief, cancer, and infections, showcasing their remarkable antimicrobial efficacy. In this review, we provide a comprehensive investigation into the potential of venom-derived compounds for developing new antimicrobial agents, including antibacterial, antifungal, antiviral, and antiparasitic therapeutics. Key venom components, including melittin from bee venom, phospholipase A2 from snake venom, and chlorotoxin from scorpion venom, exhibit potent antimicrobial effects through mechanisms such as membrane disruption, enzymatic inhibition, and immune modulation. We also explore the challenges related to the development and clinical use of venom-derived antimicrobials, including toxicity, stability, and delivery mechanisms. These compounds hold immense promise as transformative tools against resistant pathogens, offering a unique avenue for groundbreaking advancements in antimicrobial research and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsVenomsAnimalsHumans

Stichwörter der Autor:innen

animal venomsantibioticsantimicrobial peptidesdrug discoverymulti-drug resistantnatural products

Substanzen

Anti-Infective AgentsVenoms

Autor:innen und Institutionen

  • Biochemistry Division, Chemistry Department, Faculty of Science, Minia University, El-Minia 61519, Egypt.
  • Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt.
  • College of Integrative Studies, Abdullah Al Salem University, Khaldiya 72303, Kuwait.

ORCID-Profile: Esraa Yasser Rabea, Ahmed M Hegazy, Ahmed Al-Sabi, Tarek Mohamed Abd El-Aziz

Förderung

  • College of Integrative Studies at Abdullah Al Salem University

Zitieren

APA

Rabea, E. Y., Mahmoud, E. D., Mohamed, N. K., Ansary, E. R., Alrouby, M. R., Shehata, R. R., Mokhtar, Y. Y., Arullampalam, P., Hegazy, A. M., Al-Sabi, A., & Abd El-Aziz, T. M. (2025). Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents. Toxins, 17(5), 238. https://doi.org/10.3390/toxins17050238

Vancouver

Rabea EY, Mahmoud ED, Mohamed NK, Ansary ER, Alrouby MR, Shehata RR, et al. Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents. Toxins. 2025;17(5):238. doi:10.3390/toxins17050238

BibTeX
@article{Rabea2025,
  author = {Rabea, Esraa Yasser and Mahmoud, Esraa Dakrory and Mohamed, Nada Khaled and Ansary, Erada Rabea and Alrouby, Mahmoud Roushdy and Shehata, Rabab Reda and Mokhtar, Youssef Yasser and Arullampalam, Prakash and Hegazy, Ahmed M and Al-Sabi, Ahmed and Abd El-Aziz, Tarek Mohamed},
  title = {Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents},
  journal = {Toxins},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {238},
  doi = {10.3390/toxins17050238}
}
Kostenlos starten →